 Connection
Anosheh Afghahi to Treatment Outcome
This is a "connection" page, showing publications Anosheh Afghahi has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.036 |
|
|
|
-
Dong S, Banerjee R, Khan AM, Wang M, Wang X, Afghahi A, Afrough A, Janakiram M, Wang B, Cowan AJ, Sperling AS, Anderson LD, Rajkumar SV, Kaur G. Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis. Blood Cancer J. 2025 Mar 28; 15(1):48.
Score: 0.022
-
West AH, Knollman H, Dugan J, Hedeker D, Handorf EA, Nielsen SM, Bealin LC, Goldblatt LG, Willems H, Daly MB, Afghahi A, Olopade OI, Hulick PJ, Shagisultanova E, Huo D, Obeid E, Churpek JE. Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study. Cancer Med. 2019 09; 8(12):5609-5618.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|